GL1X · GenesisL1 explorer

MolNFT v1 · #53394 · protein

Crystal structure of CHK2 in complex with an inhibitor

2WTD · SERINE/THREONINE-protein kinase CHK2: “Crystal structure of CHK2 in complex with an inhibitor”. X-ray diffraction, 2 ligands (ZZK, NO3), 3 pockets (best druggability 0.57). MolNFT v1 #53394 on GenesisL1: 3D structure, binding sites…

PDB
2WTD
Type
protein
Length
285 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
ZZK, NO3
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28541% helix, 17% strandO96017

Ligands and binding sites

  • ZZK · 4-[2-amino-5-(1,3-benzodioxol-4-yl)pyridin-3-yl]benzamide · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12260.570.7927ZZK
21220.380.7419empty
3890.320.7321empty

Compared structures

  • 2WTD · Crystal structure of Chk2 in complex with an inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.